Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Maira-Litrán, T.
Right arrow Articles by Gilbert, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maira-Litrán, T.
Right arrow Articles by Gilbert, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2000) 45, 789-795
© 2000 The British Society for Antimicrobial Chemotherapy

An evaluation of the potential of the multiple antibiotic resistance operon (mar) and the multidrug efflux pump acrAB to moderate resistance towards ciprofloxacin in Escherichia coli biofilms

T. Maira-Litrán, David G. Allison and P. Gilbert*

School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Oxford Road, Manchester M13 9PL, UK

The chromosomal multiple antibiotic resistance operon, mar, is widely represented amongst Gram-negative bacteria and has been implicated in resistance towards oxidative stress agents, organic solvents and a large number of structurally unrelated antimicrobial agents. The major mechanism associated with such increased resistance is an upregulation of the efflux pump acrAB. Growth as a biofilm is often associated with similar generalized reductions in susceptibility to inimical agents. Escherichia coli K12 (AG100), an isogenic mutant of AG100 constitutive for mar expression (AG102) and an isolate deleted of the mar locus (MCH164) were grown as biofilms in cellulose-fibre depth filters and perfused with a simple salts, minimal medium (CDM) over 120 h. Biofilms were exposed to various concentrations of ciprofloxacin (0.004, 0.015 and 0.1 mg/L) for 42 h. The numbers of viable cells within the perfusate and within the biofilm were estimated throughout. Whereas no differences were seen between the wild-type and mar-deleted isolates, that constitutive for mar displayed reduced susceptibility to ciprofloxacin at concentrations of 0.004 mg/L (MIC for AG100 was 0.0052 mg/L). Similar antibiotic perfusion experiments were conducted using isolates in which the efflux pump acrAB was either deleted (AG100-A) or constitutively expressed (AG100-B). Exposure of AG100-A biofilms to ciprofloxacin at 0.004 and 0.1 mg/L showed similar susceptibilities to those seen in the wild-type (AG100) and mar-deleted (MCH164) isolates and suggested that acrAB was not induced within the attached population. On the other hand, constitutive expression of acrAB (AG100-B) protected biofilms against the lower concentration of ciprofloxacin used (0.004 mg/L). This protection was again lost at concentrations of 0.1 mg/L. Overall, these results show that ciprofloxacin resistance in biofilms is not mediated by the upregulation of the mar or acrAB operons.

* Corresponding author. Tel: +44-161-275-2361; Fax: +44-161-275-2396; E-mail: pgilbert{at}man.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Bacteriol.Home page
M. Herzberg, I. K. Kaye, W. Peti, and T. K. Wood
YdgG (TqsA) Controls Biofilm Formation in Escherichia coli K-12 through Autoinducer 2 Transport
J. Bacteriol., January 15, 2006; 188(2): 587 - 598.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
C. N. H. Marques, V. C. Salisbury, J. Greenman, K. E. Bowker, and S. M. Nelson
Discrepancy between viable counts and light output as viability measurements, following ciprofloxacin challenge of self-bioluminescent Pseudomonas aeruginosa biofilms
J. Antimicrob. Chemother., October 1, 2005; 56(4): 665 - 671.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
A A Ramadhan and E Hegedus
Biofilm formation and esp gene carriage in enterococci
J. Clin. Pathol., July 1, 2005; 58(7): 685 - 686.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. K. Mukherjee, J. Chandra, D. M. Kuhn, and M. A. Ghannoum
Mechanism of Fluconazole Resistance in Candida albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane Sterols
Infect. Immun., August 1, 2003; 71(8): 4333 - 4340.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
Q. C. Truong-Bolduc, X. Zhang, and D. C. Hooper
Characterization of NorR Protein, a Multifunctional Regulator of norA Expression in Staphylococcus aureus
J. Bacteriol., May 15, 2003; 185(10): 3127 - 3138.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
P. Gilbert and A. J. McBain
Potential Impact of Increased Use of Biocides in Consumer Products on Prevalence of Antibiotic Resistance
Clin. Microbiol. Rev., April 1, 2003; 16(2): 189 - 208.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
A. L. Spoering and K. Lewis
Biofilms and Planktonic Cells of Pseudomonas aeruginosa Have Similar Resistance to Killing by Antimicrobials
J. Bacteriol., December 1, 2001; 183(23): 6746 - 6751.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
T. R. De Kievit, M. D. Parkins, R. J. Gillis, R. Srikumar, H. Ceri, K. Poole, B. H. Iglewski, and D. G. Storey
Multidrug Efflux Pumps: Expression Patterns and Contribution to Antibiotic Resistance in Pseudomonas aeruginosa Biofilms
Antimicrob. Agents Chemother., June 1, 2001; 45(6): 1761 - 1770.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
K. Lewis
Riddle of Biofilm Resistance
Antimicrob. Agents Chemother., April 1, 2001; 45(4): 999 - 1007.
[Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.